Sionna Therapeutics, Inc. Common Stock Long-term Investment Intensity
Sionna Therapeutics, Inc. Common Stock long-term investment intensity. Sionna Therapeutics, Inc. Common Stock (SION) has a Long-term Investment Intensity of 22.8% as of December 2025. Long-term investments of $74.42 Million represent 22.8% of total assets of $325.95 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Sionna Therapeutics, Inc. Common Stock debt and liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Sionna Therapeutics, Inc. Common Stock (2024–2025)
Long-term investment intensity of Sionna Therapeutics, Inc. Common Stock from 2024 to 2025. This chart shows how Sionna Therapeutics, Inc. Common Stock's Long-term Investment Intensity has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the intensity stands at 22.8%, reflecting long-term investments of $74.42 Million against total assets of $325.95 Million USD.
Sionna Therapeutics, Inc. Common Stock Long-term Investment Intensity by Year (2024–2025)
Sionna Therapeutics, Inc. Common Stock long-term investment intensity by year from 2024 to 2025. The table below presents the year-by-year Long-term Investment Intensity for Sionna Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Sionna Therapeutics, Inc. Common Stock balance sheet assets.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 22.8% | $74.42 Million | $325.95 Million | ▲ +11.8 pp |
| 2024 | 11.0% | $20.50 Million | $185.75 Million | — |